Immunology Program and Infectious Disease Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Immunol Rev. 2017 Sep;279(1):90-105. doi: 10.1111/imr.12563.
The human gastrointestinal tract hosts a diverse network of microorganisms, collectively known as the microbiota that plays an important role in health and disease. For instance, the intestinal microbiota can prevent invading microbes from colonizing the gastrointestinal tract, a phenomenon known as colonization resistance. Perturbations to the microbiota, such as antibiotic administration, can alter microbial composition and result in the loss of colonization resistance. Consequently, the host may be rendered susceptible to colonization by a pathogen. This is a particularly relevant concern in the hospital setting, where antibiotic use and antibiotic-resistant pathogen exposure are more frequent. Many nosocomial infections arise from gastrointestinal colonization. Due to their resistance to antibiotics, treatment is often very challenging. However, recent studies have demonstrated that manipulating the commensal microbiota can prevent and treat various infections in the intestine. In this review, we discuss the members of the microbiota, as well as the mechanisms, that govern colonization resistance against specific pathogens. We also review the effects of antibiotics on the microbiota, as well as the unique epidemiology of immunocompromised patients that renders them a particularly high-risk population to intestinal nosocomial infections.
人类胃肠道中存在着一个多样化的微生物网络,这些微生物通常被称为微生物群落,它们在健康和疾病中起着重要作用。例如,肠道微生物群落可以防止入侵的微生物在胃肠道中定植,这种现象被称为定植抵抗。微生物群落的紊乱,如抗生素的使用,会改变微生物的组成,导致定植抵抗的丧失。因此,宿主可能容易被病原体定植。这在医院环境中是一个特别相关的问题,因为抗生素的使用和抗药性病原体的暴露更为频繁。许多医院获得性感染源于胃肠道定植。由于它们对抗生素的耐药性,治疗通常非常具有挑战性。然而,最近的研究表明,操纵共生微生物群落可以预防和治疗肠道的各种感染。在这篇综述中,我们讨论了控制特定病原体定植抵抗的微生物群落成员以及相关机制。我们还回顾了抗生素对微生物群落的影响,以及免疫功能低下患者的独特流行病学特征,使他们成为肠道医院获得性感染的高风险人群。